{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:09:55Z","timestamp":1774069795990,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.03.069","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T08:15:24Z","timestamp":1239783324000},"page":"3544-3552","source":"Crossref","is-referenced-by-count":74,"title":["The mast cell activator compound 48\/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen"],"prefix":"10.1016","volume":"27","author":[{"given":"Afton L.","family":"McGowen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Shelburne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soman N.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman F.","family":"Staats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2009.03.069_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.069_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2007.11.003","article-title":"How do adjuvants work? Important considerations for new generation adjuvants","volume":"27","author":"McKee","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2009.03.069_bib3","series-title":"Proceedings of the third global vaccine research forum","author":"WHO","year":"2002"},{"issue":"19","key":"10.1016\/j.vaccine.2009.03.069_bib4","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.vaccine.2003.11.071","article-title":"European union regulatory developments for new vaccine adjuvants and delivery systems","volume":"22","author":"Sesardic","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.069_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm1757","article-title":"Mast cell activators: a new class of highly effective vaccine adjuvants","volume":"14","author":"McLachlan","year":"2008","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00418-002-0425-z","article-title":"Mast cells and macrophages in normal C57\/BL\/6 mice","volume":"118","author":"Gersch","year":"2002","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.03.069_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1176","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O\u2019Hagan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.0105-2896.2005.00279.x","article-title":"Rapidly changing perspectives about mast cells at mucosal surfaces","volume":"206","author":"Vliagoftis","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2009.03.069_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI23373","article-title":"Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909","volume":"115","author":"Speiser","year":"2005","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.vaccine.2009.03.069_bib10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.188.9.1587","article-title":"Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice","volume":"188","author":"Choi","year":"1998","journal-title":"J Exp Med"},{"issue":"6577","key":"10.1016\/j.vaccine.2009.03.069_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/381077a0","article-title":"Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-[alpha]","volume":"381","author":"Malaviya","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib12","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"Peachman","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.069_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jgm.709","article-title":"Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9","volume":"7","author":"Sawamura","year":"2005","journal-title":"J Gene Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.069_bib14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"Wack","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.03.069_bib15","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1097\/01.CCM.0000142397.38134.EF","article-title":"Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung","volume":"32","author":"Yamada","year":"2004","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.069_bib16","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.03.069_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jri.2005.06.010","article-title":"CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice","volume":"68","author":"Tengvall","year":"2005","journal-title":"Journal of Reproductive Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2567.2005.02150.x","article-title":"CpG motif acts as a \u2018danger signal\u2019 and provides a T helper type 1-biased microenvironment for DNA vaccination","volume":"115","author":"Liu","year":"2005","journal-title":"Immunology"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2009.03.069_bib19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0264-410X(03)00045-8","article-title":"A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant","volume":"21","author":"Halperin","year":"2003","journal-title":"Vaccine"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.03.069_bib20","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"Cooper","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.03.069_bib21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.aids.0000183514.37513.d2","article-title":"CpG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults","volume":"19","author":"Cooper","year":"2005","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10875-004-6244-3","article-title":"CPG 7909 an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B\u00ae HBV vaccine in healthy adults: a double-blind phase I\/II study","volume":"24","author":"Cooper","year":"2004","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.173.2.755","article-title":"Cholera toxin prevents Th1-mediated autoimmune disease by inducing immune deviation","volume":"173","author":"Bo Su","year":"2004","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.03.069_bib24","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.069_bib25","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/IAI.61.11.4919-4924.1993","article-title":"Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoni","volume":"61","author":"Akhiani","year":"1993","journal-title":"Infect Immun"},{"issue":"47","key":"10.1016\/j.vaccine.2009.03.069_bib26","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1016\/j.vaccine.2007.09.030","article-title":"Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens","volume":"25","author":"Uddowla","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.03.069_bib27","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.4049\/jimmunol.162.10.6141","article-title":"IL-1 Is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens","volume":"162","author":"Staats","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JVI.76.2.517-524.2002","article-title":"Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization","volume":"76","author":"Bradney","year":"2002","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/aid.2006.22.558","article-title":"Capric acid and hydroxypropylmethylcellulose increase the immunogenicity of nasally administered peptide vaccines","volume":"22","author":"Nordone","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.181.1.186","article-title":"B cell chemoattractant CXCL13 is preferentially expressed by human Th17 cell clones","volume":"181","author":"Takagi","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.vaccine.2006.07.037","article-title":"Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen","volume":"25","author":"Duc","year":"2007","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.03.069_bib32","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2004.10.014","article-title":"Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants","volume":"23","author":"Berthold","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"Peachman","year":"2006","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.069_bib34","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1128\/IAI.00529-07","article-title":"In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity","volume":"75","author":"Staats","year":"2007","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2009.03.069_bib35","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2007.01.075","article-title":"Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine","volume":"25","author":"Zeng","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib36","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.153.2.647","article-title":"Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin","volume":"153","author":"Snider","year":"1994","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2007.10.007","article-title":"Th17 cells: effector T cells with inflammatory properties","volume":"19","author":"Korn","year":"2007","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib38","first-page":"2113","article-title":"Vaccine adverse events: separating myth from reality","volume":"66","author":"Kimmel","year":"2002","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib39","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.4049\/jimmunol.177.6.3577","article-title":"Dendritic cell modulation by mast cells controls the Th1\/Th2 balance in responding T cells","volume":"177","author":"Mazzoni","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.069_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2005.08.003","article-title":"One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus","volume":"24","author":"Lodmell","year":"2006","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2009.03.069_bib41","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody responses after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2009.03.069_bib42","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"351","author":"Kenney","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2009.03.069_bib43","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMe048314","article-title":"Intradermal influenza vaccination\u2014can less be more?","volume":"351","author":"La Montagne","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.069_bib44","doi-asserted-by":"crossref","first-page":"e1993","DOI":"10.1371\/journal.pone.0001993","article-title":"Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial","volume":"3","author":"Roukens","year":"2008","journal-title":"PLoS ONE"},{"issue":"22","key":"10.1016\/j.vaccine.2009.03.069_bib45","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.vaccine.2008.03.016","article-title":"Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination","volume":"26","author":"Sugimura","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.069_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.vaccine.2006.08.026","article-title":"Antibody responses after dose-sparing intradermal influenza vaccination","volume":"25","author":"Auewarakul","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/IAI.72.2.1181-1183.2004","article-title":"Needle-free skin patch vaccination method for anthrax","volume":"72","author":"Matyas","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.069_bib48","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib49","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-006-0206-9","article-title":"Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic\u2013polyribocytidylic acid induced strong mucosal and systemic immunities","volume":"23","author":"Sloat","year":"2006","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.069_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1086\/427189","article-title":"Late Treatment with a Protective Antigen Directed Monoclonal Antibody Improves Hemodynamic Function and Survival in a Lethal Toxin Infused Rat Model of Anthrax Sepsis","volume":"191","author":"Cui","year":"2005","journal-title":"J Infect Dis"},{"issue":"31","key":"10.1016\/j.vaccine.2009.03.069_bib51","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib52","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.73.2.795-802.2005","article-title":"A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized Bacillus anthracis Spore Challenge","volume":"73","author":"Mohamed","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.069_bib53","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1182\/blood-2004-07-2811","article-title":"Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression","volume":"105","author":"Kataoka","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.069_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.1711640313","article-title":"Histopathological studies on the local reactions induced by complete freund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugates","volume":"164","author":"Wiedemann","year":"1991","journal-title":"J Pathol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2009.03.069_bib55","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0264-410X(02)00174-3","article-title":"Design and selection of vaccine adjuvants: animal models and human trials","volume":"20","author":"Alving","year":"2002","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2009.03.069_bib56","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1200\/JCO.2008.16.6462","article-title":"Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer","volume":"26","author":"Barve","year":"2008","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.vaccine.2009.03.069_bib57","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1016\/j.vaccine.2006.12.057","article-title":"Dermal testing of vaccines for children at high risk of allergies","volume":"25","author":"Sugai","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1503\/cmaj.080916","article-title":"Anaphylaxis following quadrivalent human papillomavirus vaccination","volume":"179","author":"Brotherton","year":"2008","journal-title":"CMAJ"},{"issue":"7","key":"10.1016\/j.vaccine.2009.03.069_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.185.7.1203","article-title":"Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain Adjuvanticity","volume":"185","author":"Yamamoto","year":"1997","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2009.03.069_bib60","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1084\/jem.188.9.1587","article-title":"Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice","volume":"188","author":"Choi","year":"1998","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.069_bib61","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jlb.67.6.841","article-title":"Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis","volume":"67","author":"Malaviya","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"6577","key":"10.1016\/j.vaccine.2009.03.069_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/381075a0","article-title":"Critical protective role of mast cells in a model of acute septic peritonitis","volume":"381","author":"Echtenacher","year":"1996","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.03.069_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.imlet.2003.10.005","article-title":"Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli","volume":"91","author":"Malaviya","year":"2004","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.069_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1600-065X.2000.17706.x","article-title":"The neutrophil as a cellular source of chemokines","volume":"177","author":"Scapini","year":"2000","journal-title":"Immunol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.tvjl.2007.12.030","article-title":"A sheep in wolf's clothes: Can neutrophils direct the immune response","volume":"180","author":"Whale","year":"2009","journal-title":"Vet J"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.069_bib66","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2006-12-063826","article-title":"Neutrophils efficiently cross-prime naive T cells in vivo","volume":"110","author":"Beauvillain","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.069_bib67","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.4049\/jimmunol.166.5.3355","article-title":"Early recruitment of neutrophils Determines Subsequent T1\/T2 host responses in a Murine Model of Legionella pneumophila pneumonia","volume":"166","author":"Tateda","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.069_bib68","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.4049\/jimmunol.158.5.2356","article-title":"An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis","volume":"158","author":"Romani","year":"1997","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.069_bib69","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.20041276","article-title":"Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN","volume":"201","author":"van Gisbergen","year":"2005","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.069_bib70","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.4049\/jimmunol.174.8.4845","article-title":"Microbial antigen triggers rapid mobilization of TNF-\u03b1 to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-\u03b1 production.","volume":"174","author":"Bennouna","year":"2005","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.03.069_bib71","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1182\/blood-2006-04-016659","article-title":"Presence of neutrophil-bearing antigen in lymphoid organs of immune mice","volume":"108","author":"Maletto","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.vaccine.2009.03.069_bib72","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1034\/j.1398-9995.2000.00322.x","article-title":"Short communication Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects","volume":"55","author":"Fadel","year":"2000","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.069_bib73","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-3476(00)90008-8","article-title":"Hyper-releasability of mast cells in family members of infants with sudden infant death syndrome and apparent life-threatening events","volume":"136","author":"Gold","year":"2000","journal-title":"J Pediatr"},{"issue":"07","key":"10.1016\/j.vaccine.2009.03.069_bib74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1258\/002221502760132386","article-title":"Skin reactivity to vasomotor agents in non-eosinophilic and eosinophilic non-allergic rhinitis","volume":"116","author":"Milo\u0161evic","year":"2002","journal-title":"J Laryngol Otol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.069_bib75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1067\/mjd.2002.120461","article-title":"Sensitivity of human scalp skin to pruritic stimuli investigated by intradermal microdialysis in vivo","volume":"47","author":"Rukwied","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.069_bib76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0091-6749(73)90128-0","article-title":"Histologic studies of human skin test responses to ragweed, compound 48\/80, and histamine","volume":"51","author":"Atkins","year":"1973","journal-title":"J Allergy Clin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T20:46:47Z","timestamp":1684961207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09004903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":76,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0264410X09004903"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}